Author:
Lee Seon-Kwang,Ha Eun-Sol,Park Heejun,Jeong Ji-Su,Ryu Hyo-Jin,Pyo Yu-Jin,Choi Du Hyung,Kim Min-Soo
Funder
National Research Foundation of Korea
Ministry of Science and ICT, South Korea
Ministry of Trade, Industry and Energy
Subject
Materials Chemistry,Physical and Theoretical Chemistry,Spectroscopy,Condensed Matter Physics,Atomic and Molecular Physics, and Optics,Electronic, Optical and Magnetic Materials
Reference36 articles.
1. Discovery and development of potent LFA-1/ICAM-1 antagonist SAR 1118 as an ophthalmic solution for treating dry eye;Zhong;ACS Med. Chem. Lett.,2012
2. Lifitegrast, a novel integrin antagonist for treatment of dry eye disease;Perez;Ocul. Surf.,2016
3. Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: results of the OPUS-1 Phase 3 Study;Sheppard;Ophthalmology,2014
4. LFA-1/ICAM-1 interaction as a therapeutic target in dry eye disease;Pflugfelder;J. Ocul. Pharmacol. Ther.,2017
5. J.R. Zeller, S. Venkatraman, E.C.A. Brot, S. Iyer, M. Hall, LFA-1 inhibitor and methods of preparation and polymorph thereof, US 9,085,553 B2, 2015.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献